Wellington Nabs $393M To Invest In Novel Drug Developers
Massachusetts-based investment manager Wellington Management said Monday it has wrapped up fundraising for its debut life sciences-focused fund after raking in $393 million from limited partners, with plans to target drug...To view the full article, register now.
Already a subscriber? Click here to view full article